Oncolytics Biotech Inc. (NASDAQ:ONCY) Q2 2024 Earnings Call Transcript August 1, 2024
Oncolytics Biotech Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.08.
Operator: Good afternoon, and welcome to Oncolytics Biotech Second Quarter 2024 Conference Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised that this call is being recorded at the company’s request. I would now like...
